Health Media Network has teamed up with the Cancer Research Institute to distribute cancer immunotherapy and clinical trials education and awareness programming.
CRI and Chordoma Foundation announced today that they have established a research partnership to advance treatment options for chordoma, an ultra-rare cancer in the sarcoma family.
Discussion of the next wave of scientific advancements in immuno-oncology by panel of industry and academic leaders
Five U.S. scientists have been awarded $1.25 million each to carry out high-risk, high-reward cancer immunology research with potential to transform cancer treatment.
30 days of immunotherapy education and awareness programming for patients, caregivers, and the general public celebrating advances in immuno-oncology research and treatment
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Combined with chemotherapy, an HPV-targeting vaccine developed by CRI scientists led to encouraging responses in women with advanced cervical cancer.
Lessons learned from cancer immunotherapy research may help to curb the COVID-19 pandemic.